Efficacy and safety comparison between two neo-adjuvant chemotherapies in treatment of locally advanced cervical carcinoma
-
摘要: 目的：对比研究静脉化疗和介入性动脉化疗结合手术2种方式治疗局部晚期宫颈癌的疗效。方法按照初始时接受治疗方法的不同，将140例局部晚期（Ib2～Ⅱb 期）宫颈癌患者分为实验组（介入性子宫动脉化疗＋手术）和对照组（静脉化疗＋手术）2组，各70例。观察治疗后患者的近期总有效率、治疗前后肿瘤直径变化情况、根治手术率、3年和5年生存率（OS）及无进展生存率（PFS）、并发症、病理危险因素（子宫宫旁浸润率、淋巴结转移率）发生情况。结果2组患者近期总体有效率均较高，但差异无统计学意义；实验组治疗后瘤体直径变小比对照组的更明显，其获得根治性手术机会比对照组高，相应的淋巴结转移率、子宫宫旁浸润率低于对照组；2组的3年期的生存率、无进展生存率无差异，但5年期生存率、无进展生存率实验组比对照组高。结论动脉介入途径新辅助化疗治疗局部晚期宫颈癌手术切净率、5年生存率均优于静脉化疗，是一种安全有效的治疗手段。Abstract: Objective To compare the efficacy and safety of intravenous chemotherapy plus operation and interventional arterial chemotherapy plus operation in treatment of patients with local-ly advanced cervical carcinoma (phases Ib2~IIb).Methods 140 patients with locally advanced cervical carcinoma (phases Ib2~IIb)were divided into experimental group (uterine artery interven-tional chemotherapy plus surgery)and control group (venous chemotherapy plus surgery)according to different initial therapeutic methods,70 cases in each group.Short-term efficacy,tumor diameter changes before and after treatment,rate of radical operation,3 and 5 years overall survival (OS), progression-free survival (PFS),complications as well as pathological risk factors (rates of para-u-terine invasion and lymph node metastasis)were observed.Results Short-term efficacy improved in both groups.The decreased tumor diameter in experimental group was significantly greater than control group,and the probability rate of patients with radical operation was significantly larger than the control group.Corresponding rates of para-uterine invasion and lymph node metastasis in the ex-perimental group were significantly lower than the control group.There were no significant differ-ences of 3 years OS and PFS between two groups,and the 5 years OS and PFS in the experimental group were higher than the control group.Conclusion For patients with locally advanced cervical carcinoma,neo-adjuvant chemotherapy with artery interventional therapy is better than intravenous chemotherapy in aspects of surgical resection rate and 5 years OS,so it is a safe and effective thera-peutic method.
-
-
期刊类型引用(8)
1. 钱秋然，张圆圆，王杰平. 探讨CT引导下放射性碘125粒子组织间植入对复发性卵巢癌的近期治疗效果. 临床研究. 2025(02): 18-21 . 
百度学术
2. 王洁，尤国美，罗君，陈羚，吕展杨. ~(125)I粒子治疗患者心理一致感在自我感受负担和生活质量的中介作用. 介入放射学杂志. 2024(12): 1349-1354 . 百度学术
3. 郭霞，林秀如，雷晓娟. 延续性护理在放射性碘125粒子植入患者院外防护的应用. 医学理论与实践. 2023(04): 695-697 . 百度学术
4. 徐燕，朱春云. 碘-125植入术后病区护理人员外周血象监测及防护. 实用临床医药杂志. 2023(13): 123-126 . 本站查看
5. 鲁雪妮，宋永春，王妮妮，丁蕊娜，王岐，杨爱民. ~(125)I粒子植入术后患者周围的辐射监测及其意义. 医学信息. 2021(04): 171-173 . 百度学术
6. 吴峰，徐红卫，郭辉，权红军，郭彦伟. CT引导下氩氦刀联合放射性粒子植入治疗非小细胞肺癌的临床疗效. 中华老年医学杂志. 2021(02): 197-202 . 百度学术
7. 单卉，陈德平，李卫平，李信，候海文. CT引导下微波消融与粒子植入治疗非小细胞肺癌的疗效分析. 南昌大学学报(医学版). 2021(04): 40-43 . 百度学术
8. 蒋婷. 经气管镜碘125粒子植入联合化疗治疗晚期中央型肺癌临床疗效探讨. 基层医学论坛. 2020(34): 4927-4929 . 百度学术
其他类型引用(0)
计量
- 文章访问数: 190
- HTML全文浏览量: 48
- PDF下载量: 0
- 被引次数: 8
下载:
苏公网安备 32100302010246号
